NCT01532895View on ClinicalTrials.gov

Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid

CompletedOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

October 31, 2012

Conditions

Pain

Interventions

DRUG

Hydromorphone HCI OROS

type= exact number, unit= mg, number=4, form= tablet, route= oral use. One tablet administered once a day. The dose may be increased if the level of pain increases or if the pain-killing effect is insufficient.

Trial Locations (11)

Unknown

Ansan

Busan

Cheongju-si

Daegu

Hwasun Gun

Incheon

Pusan

Seognam-Si, Kyungki-Do

Seoul

Suwon

Wonju-Shi

All Listed Sponsors

lead

Janssen Korea, Ltd., Korea

INDUSTRY

NCT01532895 - Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid | Biotech Hunter | Biotech Hunter